Ingrid Gisela Trifas

Dr. Ingrid Gisela Trifas


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2025 in Molecules
Verified
Journal Article
Open access
PDF file
Ranu BiswasRanu Biswas
Ranu Biswas
SMSourav Mondal
Sourav Mondal
AAAhesan Ansari
Ahesan Ansari
Tanima SarkarTanima Sarkar
Tanima Sarkar
ISIustina Petra Solomon-Condriuc
Iustina Petra Solomon-Condriuc
Leonard Ionut AtanaseLeonard Ionut Atanase
Leonard Ionut Atanase
Chitosan (CS) occurs naturally as an alkaline polysaccharide and has been demonstrated to have several activities of a biological nature. Additionally, as CS chains have functional hydroxyl and amino groups that are active, their applications can be expanded by chemically or molecularly altering the molecules to incorporate new functional groups. Due to its outstanding qualities, including biodegradability, biocompatibility, non-toxicity, and accessibility, it has received significant interest in all areas of biomedicine and nanomaterials being extremely promising as drug nanocarrier. The last decades have produced a lot of interest in CS-based nanoparticles (CSNPs), with an increasing number of research papers from around 1500 in 2015 to almost 5000 in 2024. The degree of crosslinking, the particulate system’s shape, size, and density, in addition to the drug’s physical and chemical properties, all have a role in how the drug is transported and released from CSNPs. When creating potential drug delivery systems based on CSNPs, all these factors must be considered. In earlier, CSNPs were employed to enhance the pharmacotherapeutics, pharmacokinetics, and solubility properties of drugs. By investigating its positively charged characteristics and changeable functional groups, CS has evolved into a versatile drug delivery system. The drug release from CSNPs will definitely be influenced by various changes to the functional groups, charges, and polymer backbone. This review mainly discusses the most important results published in the last decade. Despite the promising advantages of CSNPs, challenges related to the translation into clinical stages remain and further in vitro and in vivo studies are mandatory.
1

24 September 2026 in Polymers
Verified
Journal Article
Open access
PDF file
Delia Mihaela RataDelia Mihaela Rata
Delia Mihaela Rata
ITIngrid Gisela Trifas
Ingrid Gisela Trifas
Raluca SomoghiRaluca Somoghi
Raluca Somoghi
ACAnca Niculina CADINOIU
Anca Niculina CADINOIU
SGSimona Doina Matiut Grecu
Simona Doina Matiut Grecu
Leonard Ionut AtanaseLeonard Ionut Atanase
Leonard Ionut Atanase
Preparation of complex biomaterials capable of providing both controlled drug delivery and an increased antimicrobial effect without affecting healthy cells remains a major challenge in pharmaceutical and biomedical applications. This study reports the successful preparation of biocomposite microparticles based on carboxymethyl chitosan and poly (vinyl alcohol), co-loaded with zinc oxide nanoparticles with antimicrobial effect and Ibuprofen with anti-inflammatory, antipyretic, and analgesic effect. An environmentally friendly water-in-oil emulsion method using DL-limonene as a biocompatible oil phase was used to obtain these microparticles. FTIR analysis confirmed the formation of intermolecular ester and amide bonds and the successful incorporation of zinc oxide nanoparticles into the polymeric matrix. The obtained microparticles exhibited diameters ranging from 533 to 1054 nm and provided a biphasic Ibuprofen release profile, characterized by an initial burst release within the first 3 h followed by sustained diffusion-controlled release, achieving cumulative drug release of 84–100%. Biocomposite microparticles presented excellent hemocompatibility, with hemolysis values between 0.41% and 2.47%. Moreover, after 24 h of exposure to microparticles, human dermal fibroblasts exhibited a cellular viability ranging from 82.24% to 94.22% whereas prolonged treatment for 48 h resulted in a slight decrease of cell viability until 74.88%. Biocomposite microparticles exhibited notable antimicrobial activity against Streptococcus pneumoniae strain. These findings demonstrate that the combination of green fabrication, controlled Ibuprofen release, good biocompatibility, and antimicrobial efficacy highlights the potential of these biocomposite microparticles as innovative hybrid nanostructures that can significantly improve therapeutic outcomes.